NCT06546007View on ClinicalTrials.gov

Rarecells Molecular Biomarkers for Early Detection of Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

October 1, 2025

Conditions
Lung CancerPulmonary Neoplasm
Interventions
DIAGNOSTIC_TEST

CTC-DNA

ctDNA for the analysis of lung cancer mutations in patients with operable tumors.

Trial Locations (1)

Unknown

RECRUITING

Università Cattolica del Sacro Cuore Gemelli Hospital, Roma

Sponsors

Collaborators (1)

Meditrial SrL
All Listed Sponsors
collaborator

Meditrial Europe Ltd.

INDUSTRY

collaborator

Meditrial SrL

INDUSTRY

lead

Rarecells Diagnostics SAS

INDUSTRY

NCT06546007 - Rarecells Molecular Biomarkers for Early Detection of Lung Cancer | Biotech Hunter | Biotech Hunter